+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Next Generation Sequencing"

From
From
From
Short-Read Sequencing - Global Strategic Business Report 2026 - Product Thumbnail Image

Short-Read Sequencing - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 166 Pages
  • Global
From
Optical Genome Mapping - Global Strategic Business Report 2026 - Product Thumbnail Image

Optical Genome Mapping - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 208 Pages
  • Global
From
From
Rare Cell Isolation - Global Strategic Business Report 2026 - Product Thumbnail Image

Rare Cell Isolation - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 170 Pages
  • Global
From
Cloning and Mutagenesis - Global Strategic Business Report 2026 - Product Thumbnail Image

Cloning and Mutagenesis - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 178 Pages
  • Global
From
Multiomics - Global Strategic Business Report 2026 - Product Thumbnail Image

Multiomics - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 209 Pages
  • Global
From
From
Peptide Microarray - Global Strategic Business Report 2026 - Product Thumbnail Image

Peptide Microarray - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 168 Pages
  • Global
From
DNA Repair Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

DNA Repair Drugs - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 217 Pages
  • Global
From
Nucleotide - Global Strategic Business Report 2026 - Product Thumbnail Image

Nucleotide - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 182 Pages
  • Global
From
Sanger Sequencing - Global Strategic Business Report 2026 - Product Thumbnail Image

Sanger Sequencing - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 178 Pages
  • Global
From
Digital Genomes - Global Strategic Business Report 2026 - Product Thumbnail Image

Digital Genomes - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 184 Pages
  • Global
From
Bioburden Testing - Global Strategic Business Report 2026 - Product Thumbnail Image

Bioburden Testing - Global Strategic Business Report 2026

  • Report
  • October 2026
  • 281 Pages
  • Global
From
From
From
Biomanufacturing - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • October 2026
  • 375 Pages
  • Global
From
From
Loading Indicator

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species. The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more